Global Summit on Stroke August 03-05, 2015 Birmingham, UK

Dr. Howard Prentice obtained his Ph.D. from the University of London, UK and after post-doctoral training in the USA held a faculty position at the University of Glasgow, UK from 1993-2000. He then joined Florida Atlantic University in Boca Raton where he is currently associate professor of Biomedical Sciences in the College of Medicine. From 2013-2014 he was visiting associate professor at Harvard Medical School, Boston. Dr. Prentice has more than 60 peer reviewed publications. He has been serving on study sections for the American Heart Association and the NIH and on editorial boards of several international scientific journals.

Dr. ZhiGang Xiong is Director of the Neurophysiology Program of the R. S. Dow Neurobiology Laboratories at the Legacy Clinical Research Center. Dr. Xiong is an inventor of our acute stroke therapy.Dr. Xiong received his M.D. from Anhui Medical University in 1984 and M.Sc. from Sun Yet-Sen University of Medical Science in 1987. He received his Ph.D. from the Department of Pharmacology at the University of Ottawa in 1995 and had his postdoctoral training in the Department of Physiology at the University of Toronto from 1995 to 1999. He is a recognized expert on the function of ion channels and membrane receptors in ischemic brain injury. Dr. Xiong has been awarded $4 million in grants from the NIH/NINDs to fund ion channel research.

He received Ph.D from University of California. Currently he is working as associate Dean for Research Department of Biomedical Science at Florida Atlantic University.

Structure and Function of Neurotransmitter Enzymes and Receptors; Mechanism of Signal Transduction and Neuronal Degeneration; Neurotransmission and Neurological Disorders.

Dr. Byron D. Ford is a Professor in the Department of Neurobiology and the Director of the Neuroprotection, Neurorepair and Stroke Program at the Morehouse School of Medicine in Atlanta, GA. Dr. Ford is an expert in the cellular and molecular events associated with stroke and acute brain injuries. In 2005 he published a groundbreaking research article showing that neureglin-1 can protect neurons and reduce inflammation in an animal model of stroke. Dr. Ford received his Ph.D. from Meharry Medical College and completed postdoctoral studies at Harvard Medical School and the NIH. Dr. Ford has received numerous honors and recent recognition by the Southeast BIO Investor.

Dr. Robin Sellar is Head of the Neuroradiology Department. He has built up the Interventional Neuroradiology department over the past 15 years. He is editor in chief of Neurointerventionalist, an editor of Neuroradiology and also of Patient Centred Care. Dr Sellar holds degrees in Psychology as well as Medicine and uniquely in this country he is not only a Fellow of the Royal College of Radiologists but also the Colleges of Physicians and Surgeons. He has written extensively on neurovascular intervention with over 75 publications in the last 5 years including many contributions to books. He has been awarded 8 prizes and scholarships for his academic work.

Dr. Bayley is currently the Medical Director of the Brain and Spinal Cord rehabilitation Program at the UHN- Toronto Rehabilitation Institute. He is currently an Associate Professor at University of Toronto. He is appointed as a Clinician Scientist at Toronto Rehab and associate scientist at the Institute for Clinical and Evaluative Sciences (ICES) and the Heart and Stroke Foundation Centre for Stroke Recovery. He has a strong interest in the field of knowledge translation i.e. how the best evidence can be implemented into practice and how to measure its uptake by clinicians. He is one of the Principle investigators on the Canadian Stroke Network SCORE project (Stroke Canada Optimization of Rehabilitation by Evidence). He is co-chair of the Best Practices committee and author of the Best Practice Guidelines for the Canadian Stroke strategy. He also chairs the Stroke Evaluation Advisory Committee of the Ontario Stroke Network. He has 65 publications in his areas of research and has co-authored web-based guidelines, application and systematic reviews.

Dr Schmidt is a member of the European Force on Age-related White Matter Changes. He is also a member of the Austrian Society of Neuroimaging, and the Austrian Society for Stroke Research, and the president of the Austrian Alzheimer Society, and of the Working Group Neuroepidemiology and Prevention of the Austrian Neurological Society. He is a member of the VITATOPS-Steering Committee: a worldwide project on homocysteine-lowering multivitamin therapy in patients with recent ischaemic attacks or stroke. Dr Schmidt is or has been a principle investigator in the CASCADE study on diabetes and cortical atrophy stratified by abscence and presence of hypertension, in the Honolulu-Asia Aging Study, and in the Austrian Stroke Prevention Study.

Dr Schmidt`s clinical and research interests focus on the managing and treatment of vascular dementia combined with cerebrovascular diseases, in the pathophysiology of vascular cognitive impairment and Alzheimer`s Disease, in white matter lesion progression in patients with small vessel diseases, and in the prevention of diabetes.

Dr. Andreas GRUBER is Medical School at University of Vienna, Austria, with graduation 1992; Board certified in Austria for Neurosurgery and Intensive Care Medicine;Associate Professor of Neurosurgery since 2001. He was Austrian representative to the European Association of Neurosurgical Societies [EANS] and ExCom member of the EANS cerebrovascular section. His Clinical work and research focused on microsurgical and endovascular management of cerebrovascular diseases and neurosurgical intensive care medicine.

Professor Jan More wood is physiotherapist since 1997 BSc in 2005 Master in Public Health in 2006. Dr. rer. medic . In 2007 , habilitation in 2010 professor in physiotherapy since 2008. He is head of the scientific institutions in Kreischa , Germany and so lecturer at the Department of Public Health , University of Dresden , Germany .

His main research interests are in neurological rehabilitation and motor workout after stroke and other neurological diseases . He works as a researcher in this field.

Dr Staykov’s recent research is related to the treatment of intraventricular hemorrhage, the development of imaging analysis techniques and quantification of perihemorrhagic brain edema, and therapeutic hypothermia in ischemic and hemorrhagic stroke. He is a member of the Executive Committee and Regional Coordinator for Middle and South-Eastern Europe for the EuroHYP-1 trial. Dr Staykov has published more than 50 peer-reviewed articles in international scientific journals and has co-authored guidelines of the Neurocritical Care Society and the European Stroke Organization.

Dr. Hen Hallevi is attending physician, department of Neurology, Soroka Medical Center, Beer-Sheva, Israel; Vascular Neurology fellow, University of Texas at Houston and he is attending physician, Neurology department and Stroke unit, Tel-Aviv Sourasky, MC, Tel-Aviv, Israel.

Dr. Yukito SHINOHARA graduated from Keio University School of Medicine, Tokyo, Japan. He became Professor and Chairman of Neurology, Tokai University School of Medicine on 1983 and worked as a clinical neurologist, and clinical researcher of stroke and cerebral hemodynamics. He is currently Member at Large of World Stroke Organization, Immediate Past President of the Japan Stroke Society and the Asia Pacific Stroke Organization, and Chairman of the Japanese Stroke Guidelines in 2004 and 2009. His present　 position is a Director, Federation of National Public Service Personnel Mutual Aid Associations Tachikawa Hospital, Tokyo, and Professor Emeritus, Tokai University School of Medicine. He published 201 original papers and 8 reviews in English, and also wrote more than 256 original papers and 500 reviews and text books in Japanese

Stroke treatment

Dr. Paul Macaire OSSOU-NGUIET work actively for the development of neurovascular Congo. Main editor of the national plan of action against stroke in Congo, he set up the first stroke unit in Central Africa, and is the first to achieve thrombolysis in the acute phase of stroke in Central Africa. Author of several publications in African and international journals in the field of general neurology and in stroke. He was one of the investigator of CADISP study in the Lille team.

Stroke Treatment

Dr. Wang is Director of Neuroapoptosis Drug Discovery Laboratory, Department of Neurosurgery, Brigham and Women’s Hospital/Harvard Medical School. Dr. Wang received her PhD from Hebrew University of Jerusalem. She did her postdoctoral training at University of Michigan and Harvard Medical School. Dr. Wang has published about 70 peer-reviewed articles and has served as the Guest Editor, Handling Editor, and Editorial Board Member for a number of peer-reviewed journals, as well as the scientist reviewer for institutes or foundations including NIH, DOD, BSF, and others, and invited reviewer for 30 peer-reviewed journals.

The identification of candidate therapeutics and potential targets for therapeutic intervention in neurological disorders including adult stroke, newborn brain injury, Amyotrophic Lateral Sclerosis, and Huntington’s disease. Another main interest concerns the fundamental mechanisms of neurological diseases.

Dr. Andrew Grande originates from Minneapolis/St. Paul. He grew up in the Minneapolis lakes area and then later moved to St. Paul where he attended St. Thomas Academy for high school. He graduated from St. Olaf College (Northfield, MN) with a BA in chemistry and then attended the University of Minnesota Medical School. During college and medical school, he was very active in research activities at the University of Minnesota, working in the laboratories of Esam El. Fakahany, Virginia Seybold and Walter Low. These experiences later culminated in a burning curiosity and passion for the use of stem cells to treat stroke.

Dr. Vijay K Sharma is the current recipient of the prestigious Clinician Scientist Award from National Medical Research Council, Singapore. He has published 187 peer reviewed scientific papers and 19 book chapters. Dr. Sharma is Associate Editor for BMC Neurology and serves on the editorial boards of many scientific journals including Stroke, Journal of Stroke, Neural Regeneration Research, Recent Patents on Medical Imaging, Journal of Behavioral and Brain Science, World Journal of Hypertension, ISRN Neurology, American Journal of Cardiovascular Diseases, World Journal of Neurology, Journal of Neurology & Translational Neuroscience (JNTN), International Journal of Medical Sciences and Biotechnology, Advances in Neuroscience Research and Neurological Research and Therapy.

Thrombolysis in acute stroke, especially sonothrombolysis, Blood pressure management in acute ischemic stroke, Advanced applications of transcranial Doppler in cerebrovascular diseases, Intracranial stenosis, Assessment of cerebral hemodynamics with cerebrovascular ultrasonography.